Skip to content
MedsAcross

Medicine

Hydrochlorothiazide and Spironolactone 25 mg/25 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Hydrochlorothiazide and Spironolactone 25 mg/25 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Hydrochlorothiazide and Spironolactone
Brand
Sold under the generic name
Strength
25 mg/25 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 1000 tablets and 23 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaBryant Ranch PrepackAdvagen PharmaMylan PharmaceuticalsMylan InstitutionalPrasco LaboratoriesSafecor Health
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
3 August 1979
Identifiers
RxCUI 198224DailyMed set ID c5258ea3-3aac-48fd-be5a-f8e4a47ca94a, f2a4fbc0-650b-440d-9555-c1720fe0fe35, 905568ae-ce27-4978-90c7-b5c93279ecd1 +9NDC 71335-2202, 42292-017, 63629-1069 +9Application ANDA089534, ANDA086513, NDA012616 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle, plastic53489-144-01Sun Pharmaceutical IndustriesIndia2 July 1987
500 tablet in 1 bottle, plastic53489-144-05Sun Pharmaceutical IndustriesIndia2 July 1987
1000 tablet in 1 bottle, plastic53489-144-10Sun Pharmaceutical IndustriesIndia2 July 1987
30 tablet in 1 bottle72888-040-01Advagen Pharma10 September 2026
100 tablet in 1 bottle72888-040-02Advagen Pharma10 September 2026
1000 tablet in 1 bottle72888-040-03Advagen Pharma10 September 2026
100 blister pack in 1 carton / 1 tablet in 1 blister pack42292-017-20Mylan Institutional12 May 2017
100 tablet in 1 bottle, plastic0378-0403-01Mylan Pharmaceuticals3 August 1979
500 tablet in 1 bottle, plastic0378-0403-05Mylan Pharmaceuticals3 August 1979
100 tablet in 1 bottle, plastic63629-1068-1Bryant Ranch Prepack2 July 1987
500 tablet in 1 bottle, plastic63629-1069-1Bryant Ranch Prepack2 July 1987
30 tablet in 1 bottle, plastic63629-1071-1Bryant Ranch Prepack15 September 2020
60 tablet in 1 bottle, plastic63629-1071-2Bryant Ranch Prepack24 September 2020
1000 tablet in 1 bottle, plastic63629-1071-3Bryant Ranch Prepack21 September 2020
100 tablet in 1 bottle, plastic71335-2202-1Bryant Ranch Prepack4 August 2023
100 tablet in 1 bottle71335-2674-1Bryant Ranch Prepack26 June 2025
30 tablet in 1 bottle71335-2674-2Bryant Ranch Prepack26 June 2025
60 tablet in 1 bottle71335-2674-3Bryant Ranch Prepack26 June 2025
1000 tablet in 1 bottle, plastic72162-1625-0Bryant Ranch Prepack5 August 2024
100 tablet in 1 bottle, plastic72162-1625-1Bryant Ranch Prepack5 August 2024
30 tablet in 1 bottle, plastic72162-1625-3Bryant Ranch Prepack5 August 2024
1000 tablet in 1 bottle, plastic72162-1625-4Bryant Ranch Prepack5 August 2024
500 tablet in 1 bottle, plastic72162-1625-5Bryant Ranch Prepack5 August 2024
60 tablet in 1 bottle, plastic72162-1625-6Bryant Ranch Prepack5 August 2024
100 tablet, film coated in 1 bottle66993-188-02Prasco Laboratories29 November 2021
100 blister pack in 1 carton / 1 tablet in 1 blister pack48433-090-20Safecor Health5 May 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 27 January 1961Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Hydrochlorothiazide and Spironolactone is a fixed-dose combination of an aldosterone antagonist and a thiazide diuretic indicated for edematous conditions for patients with, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Hydrochlorothiazide and Spironolactone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Hydrochlorothiazide and Spironolactone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Hydrochlorothiazide and Spironolactone 25 mg/25 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.